Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon South Korea10-2016-7019097Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon India201617023312Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Hong Kong17105504.9Filed on 2017-06-02
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon China201480074163.2Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon BrazilBR112016013804-0Filed on 2014-12-16
MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE Read more about MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE Patent Cooperation TreatyPCT/US2016/052496Filed on 2016-09-19
Reversible Regulation Of Intein Activity Through Engineered New Zinc Binding Domain Read more about Reversible Regulation Of Intein Activity Through Engineered New Zinc Binding Domain US Patent 9,796,967Filed on 2015-01-30
Selective Propagation, Maintenance, And Induction Of Nephron Stem Cells Read more about Selective Propagation, Maintenance, And Induction Of Nephron Stem Cells Japan2015-139271Filed on 2015-07-27
Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies Read more about Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies United Kingdom06734177.6Filed on 2006-02-01
Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies Read more about Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies France06734177.6Filed on 2006-02-01